Role of genetics in the diagnosis and prognosis of Crohn's disease

World Journal of Gastroenterology

Volumn 17, Issue 48, 2011, Pages 5246-5259

  Tsianos, Epameinondas V ^a   Katsanos, Konstantinos H ^a   Tsianos, Vasileios E ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Crohn's disease; Diagnosis; Genetic consortium; Genetics; Genome wide scan; Polymorphism; Prognosis

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; DISCS LARGE HOMOLOG 5 PROTEIN; FRAGILE HISTIDINE TRIAD PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERLEUKIN 23 RECEPTOR; METHOTREXATE; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3; PROTEIN; STAT3 PROTEIN; STEROID; THIOPURINE METHYLTRANSFERASE; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTHRITIS; ARTICLE; AUTOIMMUNITY; AUTOPHAGY; CD4+ T LYMPHOCYTE; COPY NUMBER VARIATION; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DYSPLASIA; ENZYME ACTIVITY; ERYTHEMA NODOSUM; ETHNIC GROUP; EYE DISEASE; FRAMESHIFT MUTATION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HOMEOSTASIS; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; KIDNEY CARCINOMA; LINKAGE ANALYSIS; LYMPHOCYTE DIFFERENTIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR CLONING; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NONHUMAN; PANETH CELL; PATHOGENESIS; PHARMACOGENETICS; PROGNOSIS; SARCOIDOSIS; SECONDARY IMMUNE RESPONSE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN MANIFESTATION; SPONDYLOARTHROPATHY; STEROID THERAPY; TREATMENT RESPONSE; UVEITIS;

EID: 84455173362     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i48.5246     Document Type: Article

References (156)

1. Achkar JP, Duerr R. The expanding universe of infamma-tory bowel disease genetics. Curr Opin Gastroenterol 2008; 24: 429-434
2. Van Limbergen J, Wilson DC, Satsangi J. The genetics of Crohn's disease. Annu Rev Genomics Hum Genet 2009; 10: 89-116
3. van Heel DA, Ghosh S, Butler M, Hunt KA, Lundberg AM, Ahmad T, McGovern DP, Onnie C, Negoro K, Goldthorpe S, Foxwell BM, Mathew CG, Forbes A, Jewell DP, Playford RJ. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 2005; 365: 1794-1796
4. Yamamoto S, Ma X. Role of Nod2 in the development of Crohn's disease. Microbes Infect 2009; 11: 912-918
5. Colombel JF. The CARD15 (also known as NOD2) gene in Crohn's disease: are there implications for current clinical practice? Clin Gastroenterol Hepatol 2003; 1: 5-9
6. Henckaerts L, Van Steen K, Verstreken I, Cleynen I, Franke A, Schreiber S, Rutgeerts P, Vermeire S. Genetic risk profling and prediction of disease course in Crohn's disease patients. Clin Gastroenterol Hepatol 2009; 7: 972-980.e2
7. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas G. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821-823
8. Vermeire S. Review article: genetic susceptibility and application of genetic testing in clinical management of infamma-tory bowel disease. Aliment Pharmacol Ther 2006; 24 Suppl 3: 2-10
9. Boedeker EC. Gut microbes, the innate immune system and infammatory bowel disease: location, location, location. Curr Opin Gastroenterol 2007; 23: 1-3
10. Vermeire S. DLG5 and OCTN. Infamm Bowel Dis 2004; 10: 888-890
11. Pugazhendhi S, Amte A, Balamurugan R, Subramanian V, Ramakrishna BS. Common NOD2 mutations are absent in patients with Crohn's disease in India. Indian J Gastroenterol 2008; 27: 201-203
12. Leong RW, Armuzzi A, Ahmad T, Wong ML, Tse P, Jewell DP, Sung JJ. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther 2003; 17: 1465-1470
13. Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, Inohara N, Núñez G, Kishi Y, Koike Y, Shimosega-wa T, Shimoyama T, Hibi T. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002; 123: 86-91
14. Molnar T, Hofner P, Nagy F, Lakatos PL, Fischer S, Lakatos L, Kovacs A, Altorjay I, Papp M, Palatka K, Demeter P, Tu-lassay Z, Nyari T, Miheller P, Papp J, Mandi Y, Lonovics J. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/ CARD15 in Hungarian patients with Crohn's disease. Dig Liver Dis 2007; 39: 1064-1070
15. Browning BL, Annese V, Barclay ML, Bingham SA, Brand S, Büning C, Castro M, Cucchiara S, Dallapiccola B, Drummond H, Ferguson LR, Ferraris A, Fisher SA, Gearry RB, Glas J, Henckaerts L, Huebner C, Knafelz D, Lakatos L, Lakatos PL, Latiano A, Liu X, Mathew C, Müller-Myhsok B, Newman WG, Nimmo ER, Noble CL, Palmieri O, Parkes M, Peter-mann I, Rutgeerts P, Satsangi J, Shelling AN, Siminovitch KA, Török HP, Tremelling M, Vermeire S, Valvano MR, Witt H. Gender-stratifed analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts. J Med Genet 2008; 45: 36-42
16. Newman B, Gu X, Wintle R, Cescon D, Yazdanpanah M, Liu X, Peltekova V, Van Oene M, Amos CI, Siminovitch KA. A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster infuences phenotypic expression of Crohn's disease. Gastroenterology 2005; 128: 260-269
17. De Jager PL, Franchimont D, Waliszewska A, Bitton A, Cohen A, Langelier D, Belaiche J, Vermeire S, Farwell L, Goris A, Libioulle C, Jani N, Dassopoulos T, Bromfeld GP, Dubois B, Cho JH, Brant SR, Duerr RH, Yang H, Rotter JI, Silverberg MS, Steinhart AH, Daly MJ, Podolsky DK, Louis E, Hafler DA, Rioux JD. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun 2007; 8: 387-397
18. Bokoch GM. Regulation of innate immunity by Rho GTPas-es. Trends Cell Biol 2005; 15: 163-171
19. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005; 5: 446-458
20. Watanabe T, Kitani A, Strober W. NOD2 regulation of Tolllike receptor responses and the pathogenesis of Crohn's disease. Gut 2005; 54: 1515-1518
21. Pierik M, Joossens S, Van Steen K, Van Schuerbeek N, Vlie-tinck R, Rutgeerts P, Vermeire S. Toll-like receptor-1, -2, and -6 polymorphisms infuence disease extension in infamma-tory bowel diseases. Infamm Bowel Dis 2006; 12: 1-8
22. Perrier C, Rutgeerts P. Cytokine blockade in infammatory bowel diseases. Immunotherapy 2011; 3: 1341-1352
23. Török HP, Glas J, Tonenchi L, Lohse P, Müller-Myhsok B, Limbersky O, Neugebauer C, Schnitzler F, Seiderer J, Tillack C, Brand S, Brünnler G, Jagiello P, Epplen JT, Griga T, Klein W, Schiemann U, Folwaczny M, Ochsenkühn T, Folwaczny C. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut 2005; 54: 1421-1427
24. Geboes K. From inflammation to lesion. Acta Gastroenterol Belg 1994; 57: 273-284
25. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997; 92: 5S-11S
26. Achkar JP, Fiocchi C. Gene-gene interactions in infamma-tory bowel disease: biological and clinical implications. Am J Gastroenterol 2009; 104: 1734-1736
27. Friedrichs F, Henckaerts L, Vermeire S, Kucharzik T, Seeha-fer T, Möller-Krull M, Bornberg-Bauer E, Stoll M, Weiner J. The Crohn's disease susceptibility gene DLG5 as a member of the CARD interaction network. J Mol Med (Berl) 2008; 86: 423-432
28. Vermeire S, Pierik M, Hlavaty T, Claessens G, van Schuer-beeck N, Joossens S, Ferrante M, Henckaerts L, Bueno de Mesquita M, Vlietinck R, Rutgeerts P. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD. Gastroen-terology 2005; 129: 1845-1853
29. Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, Epplen JT, Schmiegel WH, Griga T. A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene. Int J Colorectal Dis 2004; 19: 153-156
30. Xiao TS. Subversion of innate immune signaling through molecular mimicry. J Clin Immunol 2010; 30: 638-642
31. Dong Y, Undyala VV, Gottlieb RA, Mentzer RM, Przyklenk K. Autophagy: defnition, molecular machinery and potential role in myocardial ischemia-reperfusion injury. J Cardiovasc Pharmacol 2010
32. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, Shugart YY, Griffths AM, Targan SR, Ippoliti AF, Bernard EJ, Mei L, Nicolae DL, Regueiro M, Schumm LP, Stein-hart AH, Rotter JI, Duerr RH, Cho JH, Daly MJ, Brant SR. Genome-wide association study identifes new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007; 39: 596-604
33. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, Albrecht M, Mayr G, De La Vega FM, Briggs J, Günther S, Prescott NJ, Onnie CM, Häsler R, Sipos B, Fölsch UR, Len-gauer T, Platzer M, Mathew CG, Krawczak M, Schreiber S. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in AT-G16L1. Nat Genet 2007; 39: 207-211
34. McCarroll SA, Huett A, Kuballa P, Chilewski SD, Landry A, Goyette P, Zody MC, Hall JL, Brant SR, Cho JH, Duerr RH, Silverberg MS, Taylor KD, Rioux JD, Altshuler D, Daly MJ, Xavier RJ. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 2008; 40: 1107-1112
35. Kaser A, Blumberg RS. Adaptive immunity in infammatory bowel disease: state of the art. Curr Opin Gastroenterol 2008; 24: 455-461
36. Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009; 58: 1152-1167
37. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH. A genome-wide association study identifes IL23R as an infammatory bowel disease gene. Science 2006; 314: 1461-1463
38. Dubinsky MC, Wang D, Picornell Y, Wrobel I, Katzir L, Quiros A, Dutridge D, Wahbeh G, Silber G, Bahar R, Mengesha E, Targan SR, Taylor KD, Rotter JI. IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease. Infamm Bowel Dis 2007; 13: 511-515
39. Amre DK, Mack DR, Morgan K, Israel D, Deslandres C, Se-idman EG, Lambrette P, Costea I, Krupoves A, Fegury H, Dong J, Grimard G, Levy E. Susceptibility loci reported in genome-wide association studies are associated with Crohn' s disease in Canadian children. Aliment Pharmacol Ther 2010; 31: 1186-1191
40. Sato K, Shiota M, Fukuda S, Iwamoto E, Machida H, Inamine T, Kondo S, Yanagihara K, Isomoto H, Mizuta Y, Kohno S, Tsukamoto K. Strong evidence of a combination polymorphism of the tyrosine kinase 2 gene and the signal transducer and activator of transcription 3 gene as a DNA-based bio-marker for susceptibility to Crohn's disease in the Japanese population. J Clin Immunol 2009; 29: 815-825
41. Sugimoto K. Role of STAT3 in infammatory bowel disease. World J Gastroenterol 2008; 14: 5110-5114
42. Yamazaki K, Takahashi A, Takazoe M, Kubo M, Onouchi Y, Fujino A, Kamatani N, Nakamura Y, Hata A. Positive association of genetic variants in the upstream region of NKX2-3 with Crohn's disease in Japanese patients. Gut 2009; 58: 228-232
43. Tremelling M, Parkes M. Genome-wide association scans identify multiple confirmed susceptibility loci for Crohn's disease: lessons for study design. Infamm Bowel Dis 2007; 13: 1554-1560
44. Lees CW, Satsangi J. Genetics of infammatory bowel disease: implications for disease pathogenesis and natural history. Expert Rev Gastroenterol Hepatol 2009; 3: 513-534
45. Danese S, Gasbarrini A. Chemokines in infammatory bowel disease. J Clin Pathol 2005; 58: 1025-1027
46. Lang M, Schlechtweg M, Kellermeier S, Brenmoehl J, Falk W, Schölmerich J, Herfarth H, Rogler G, Hausmann M. Gene expression profles of mucosal fbroblasts from strictured and nonstrictured areas of patients with Crohn's disease. Infamm Bowel Dis 2009; 15: 212-223
47. Henckaerts L, Figueroa C, Vermeire S, Sans M. The role of genetics in inflammatory bowel disease. Curr Drug Targets 2008; 9: 361-368
48. Palmieri O, Latiano A, Salvatori E, Valvano MR, Bossa F, La-tiano T, Corritore G, di Mauro L, Andriulli A, Annesec V. The -A2518G polymorphism of monocyte chemoattractant pro-tein-1 is associated with Crohn's disease. Am J Gastroenterol 2010; 105: 1586-1594
49. Amre DK, Mack DR, Morgan K, Fujiwara M, Israel D, Deslan-dres C, Seidman EG, Lambrette P, Costea I, Krupoves A, Fe-gury H, Dong J, Grimard G, Levy E. Investigation of reported associations between the 20q13 and 21q22 loci and pediatric-onset Crohn's disease in Canadian children. Am J Gastroen-terol 2009; 104: 2824-2828
50. Wang K, Zhang H, Kugathasan S, Annese V, Bradfield JP, Russell RK, Sleiman PM, Imielinski M, Glessner J, Hou C, Wilson DC, Walters T, Kim C, Frackelton EC, Lionetti P, Barabino A, Van Limbergen J, Guthery S, Denson L, Piccoli D, Li M, Dubinsky M, Silverberg M, Griffths A, Grant SF, Sat-sangi J, Baldassano R, Hakonarson H. Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am J Hum Genet 2009; 84: 399-405
51. Russell RK, Nimmo ER, Satsangi J. Molecular genetics of Crohn's disease. Curr Opin Genet Dev 2004; 14: 264-270
52. Beckly JB, Hancock L, Geremia A, Cummings JR, Morris A, Cooney R, Pathan S, Guo C, Jewell DP. Two-stage candidate gene study of chromosome 3p demonstrates an association between nonsynonymous variants in the MST1R gene and Crohn's disease. Infamm Bowel Dis 2008; 14: 500-507
53. Márquez A, Varadé J, Robledo G, Martínez A, Mendoza JL, Taxonera C, Fernández-Arquero M, Díaz-Rubio M, Gómez-García M, López-Nevot MA, de la Concha EG, Martín J, Ur-celay E. Specifc association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15(-) Crohn's disease patients. Eur J Hum Genet 2009; 17: 1304-1308
54. Machida H, Tsukamoto K, Wen CY, Shikuwa S, Isomoto H, Mizuta Y, Takeshima F, Murase K, Matsumoto N, Murata I, Kohno S, Wen CY. Crohn's disease in Japanese is associated with a SNP-haplotype of N-acetyltransferase 2 gene. World J Gastroenterol 2005; 11: 4833-4837
55. Weersma RK, Stokkers PC, Cleynen I, Wolfkamp SC, Henck-aerts L, Schreiber S, Dijkstra G, Franke A, Nolte IM, Rutg-eerts P, Wijmenga C, Vermeire S. Confrmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort. Am J Gastroenterol 2009; 104: 630-638
56. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Stein- hart AH, Targan SR, Xavier RJ, Libioulle C, Sandor C, Lath-Rop M, Belaiche J, Dewit O, Gut I, Heath S, Laukens D, Mni M, Rutgeerts P, Van Gossum A, Zelenika D, Franchimont D, Hu- got JP, de Vos M, Vermeire S, Louis E, Cardon LR, Anderson CA, Drummond H, Nimmo E, Ahmad T, Prescott NJ, Onnie CM, Fisher SA, Marchini J, Ghori J, Bumpstead S, Gwilliam R, Tremelling M, Deloukas P, Mansfeld J, Jewell D, Satsangi J, Mathew CG, Parkes M, Georges M, Daly MJ. Genome-wide association defnes more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40: 955-962
57. Libioulle C, Louis E, Hansoul S, Sandor C, Farnir F, Franchi- mont D, Vermeire S, Dewit O, de Vos M, Dixon A, Demarche B, Gut I, Heath S, Foglio M, Liang L, Laukens D, Mni M, Zelenika D, Van Gossum A, Rutgeerts P, Belaiche J, Lathrop M, Georges M. Novel Crohn disease locus identifed by ge nome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 2007; 3: e58
58. Urcelay E, Mendoza JL, Martín MC, Mas A, Martínez A, Tax-onera C, Fernandez-Arquero M, Díaz-Rubio M, de la Concha EG. MDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients. Inflamm Bowel Dis 2006; 12: 33-37
59. Vermeire S, Satsangi J, Peeters M, Parkes M, Jewell DP, Vlie-tinck R, Rutgeerts P. Evidence for infammatory bowel disease of a susceptibility locus on the X chromosome. Gastroen-terology 2001; 120: 834-840
60. Villani AC, Lemire M, Fortin G, Louis E, Silverberg MS, Col-lette C, Baba N, Libioulle C, Belaiche J, Bitton A, Gaudet D, Cohen A, Langelier D, Fortin PR, Wither JE, Sarfati M, Rut-geerts P, Rioux JD, Vermeire S, Hudson TJ, Franchimont D. Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat Genet 2009; 41: 71-76
61. Simmons JD, Mullighan C, Welsh KI, Jewell DP. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 2000; 47: 211-214
62. Peeters M, Cortot A, Vermeire S, Colombel JF. Familial and sporadic infammatory bowel disease: different entities? In-famm Bowel Dis 2000; 6: 314-320
63. Brant SR, Shugart YY. Inflammatory bowel disease gene hunting by linkage analysis: rationale, methodology, and present status of the field. Infamm Bowel Dis 2004; 10: 300-311
64. Vignal C, Singer E, Peyrin-Biroulet L, Desreumaux P, Cha-maillard M. How NOD2 mutations predispose to Crohn's disease? Microbes Infect 2007; 9: 658-663
65. Akolkar PN, Gulwani-Akolkar B, Heresbach D, Lin XY, Fisher S, Katz S, Silver J. Differences in risk of Crohn's disease in offspring of mothers and fathers with infammatory bowel disease. Am J Gastroenterol 1997; 92: 2241-2244
66. Vermeire S, Van Assche G, Rutgeerts P. Should family members of IBD patients be screened for CARD15/NOD2 mutations? Infamm Bowel Dis 2008; 14 Suppl 2: S190-S191
67. Csillag C, Nielsen OH, Borup R, Olsen J, Bjerrum JT, Nielsen FC. CARD15 status and familial predisposition for Crohn 's disease and colonic gene expression. Dig Dis Sci 2007; 52: 1783-1789
68. Esters N, Pierik M, van Steen K, Vermeire S, Claessens G, Jo-ossens S, Vlietinck R, Rutgeerts P. Transmission of CARD15 (NOD2) variants within families of patients with infamma-tory bowel disease. Am J Gastroenterol 2004; 99: 299-305
69. Heliö T, Halme L, Lappalainen M, Fodstad H, Paavola-Sakki P, Turunen U, Färkkilä M, Krusius T, Kontula K. CARD15/ NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003; 52: 558-562
70. Shugart YY, Silverberg MS, Duerr RH, Taylor KD, Wang MH, Zarfas K, Schumm LP, Bromfield G, Steinhart AH, Griffiths AM, Kane SV, Barmada MM, Rotter JI, Mei L, Bernstein CN, Bayless TM, Langelier D, Cohen A, Bitton A, Rioux JD, Cho JH, Brant SR. An SNP linkage scan identifes signifcant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29. Genes Immun 2008; 9: 161-167
71. Radford-Smith G, Pandeya N. Associations between NOD2/ CARD15 genotype and phenotype in Crohn's disease--Are we there yet? World J Gastroenterol 2006; 12: 7097-7103
72. Lacher M, Schroepf S, Ballauff A, Lohse P, von Schweinitz D, Kappler R, Koletzko S. Autophagy 16-like 1 rs2241880 G allele is associated with Crohn's disease in German children. Acta Paediatr 2009; 98: 1835-1840
73. Baldassano RN, Bradfeld JP, Monos DS, Kim CE, Glessner JT, Casalunovo T, Frackelton EC, Otieno FG, Kanterakis S, Shaner JL, Smith RM, Eckert AW, Robinson LJ, Onyiah CC, Abrams DJ, Chiavacci RM, Skraban R, Devoto M, Grant SF, Hakonarson H. Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease. Clin Gastroenterol Hepatol 2007; 5: 972-976
74. Amre DK, Mack DR, Morgan K, Krupoves A, Costea I, Lam-brette P, Grimard G, Dong J, Feguery H, Bucionis V, Deslan-dres C, Levy E, Seidman EG. Autophagy gene ATG16L1 but not IRGM is associated with Crohn's disease in Canadian children. Infamm Bowel Dis 2009; 15: 501-507
75. Gazouli M, Pachoula I, Panayotou I, Mantzaris G, Chrousos G, Anagnou NP, Roma-Giannikou E. NOD2/CARD15, AT-G16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease. World J Gastroenterol 2010; 16: 1753-1758
76. Amre DK, Mack DR, Morgan K, Israel D, Lambrette P, Costea I, Krupoves A, Fegury H, Dong J, Grimard G, Deslandres C, Levy E, Seidman EG. Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease. Aliment Pharmacol Ther 2009; 29: 1025-1031
77. Storr M, Emmerdinger D, Diegelmann J, Pfennig S, Ochsen-kühn T, Göke B, Lohse P, Brand S. The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease. PLoS One 2010; 5: e9453
78. Sanchez R, Levy E, Costea F, Sinnett D. IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location. World J Gastroenterol 2009; 15: 3776-3782
79. Krupoves A, Seidman EG, Mack D, Israel D, Morgan K, Lam-brette P, Costea I, Deslandres C, Grimard G, Law L, Levy E, Amre DK. Associations between ABCB1/MDR1 gene polymorphisms and Crohn's disease: a gene-wide study in a pediatric population. Infamm Bowel Dis 2009; 15: 900-908
80. Biank V, Friedrichs F, Babusukumar U, Wang T, Stoll M, Broeckel U, Kugathasan S. DLG5 R30Q variant is a female-specifc protective factor in pediatric onset Crohn's disease. Am J Gastroenterol 2007; 102: 391-398
81. Essers JB, Lee JJ, Kugathasan S, Stevens CR, Grand RJ, Daly MJ. Established genetic risk factors do not distinguish early and later onset Crohn's disease. Infamm Bowel Dis 2009; 15: 1508-1514
82. Latiano A, Palmieri O, Cucchiara S, Castro M, D'Incà R, Guar-iso G, Dallapiccola B, Valvano MR, Latiano T, Andriulli A, An-nese V. Polymorphism of the IRGM gene might predispose to fstulizing behavior in Crohn's disease. Am J Gastroenterol 2009; 104: 110-116
83. Barreiro-de Acosta M, Peña AS. Clinical applications of NOD2/ CARD15 mutations in Crohn's disease. Acta Gastroenterol Latinoam 2007; 37: 49-54
84. Brand S, Staudinger T, Schnitzler F, Pfennig S, Hofbauer K, Dambacher J, Seiderer J, Tillack C, Konrad A, Crispin A, Göke B, Lohse P, Ochsenkühn T. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/ NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Infamm Bowel Dis 2005; 11: 645-652
85. Aithal GP, Day CP, Leathart J, Daly AK, Hudson M. Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population. Genes Immun 2001; 2: 44-47
86. Sabate JM, Ameziane N, Lamoril J, Jouet P, Farmachidi JP, Soulé JC, Harnois F, Sobhani I, Jian R, Deybach JC, de Prost D, Coffn B. The V249I polymorphism of the CX3CR1 gene is associated with fbrostenotic disease behavior in patients with Crohn's disease. Eur J Gastroenterol Hepatol 2008; 20: 748-755
87. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diepolder H, Marquardt A, Jagla W, Popp A, Leclair S, Herrmann K, Seiderer J, Ochsenkühn T, Göke B, Auernham-mer CJ, Dambacher J. IL-22 is increased in active Crohn's disease and promotes proinfammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2006; 290: G827-G838
88. Guagnozzi D, Cossu A, Viscido A, Corleto V, Annese V, Latiano A, Delle Fave G, Caprilli R. Acute intestinal obstruction and NOD2/CARD15 mutations among Italian Crohn's disease patients. Eur Rev Med Pharmacol Sci 2004; 8: 179-185
89. González S, Rodrigo L, Martínez-Borra J, López-Vázquez A, Fuentes D, Niño P, Cadahía V, Saro C, Dieguez MA, López-Larrea C. TNF-alpha -308A promoter polymorphism is associated with enhanced TNF-alpha production and infamma-tory activity in Crohn's patients with fstulizing disease. Am J Gastroenterol 2003; 98: 1101-1106
90. Bouma G, Poen AC, García-González MA, Schreuder GM, Felt-Bersma RJ, Meuwissen SG, Pena AS. HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fstulising Crohn's disease. Immunogenetics 1998; 47: 451-455
91. Silverberg MS. OCTNs: will the real IBD5 gene please stand up? World J Gastroenterol 2006; 12: 3678-3681
92. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, Burton PR, Davison D, Donnelly P, Easton D, Evans D, Leung HT, Marchini JL, Morris AP, Spencer CC, Tobin MD, Cardon LR, Clayton DG, Attwood AP, Boorman JP, Cant B, Everson U, Hussey JM, Jolley JD, Knight AS, Koch K, Meech E, Nutland S, Prowse CV, Stevens HE, Taylor NC, Walters GR, Walker NM, Watkins NA, Winzer T, Todd JA, Ouwehand WH, Jones RW, McArdle WL, Ring SM, Strachan DP, Pembrey M, Breen G, Clair D, Caesar S, Gordon-Smith K, Jones L, Fraser C, Green EK, Grozeva D, Hamshere ML, Holmans PA, Jones IR, Kirov G, Moskvina V, Nikolov I, O'Donovan MC, Owen MJ, Craddock N, Collier DA, Elkin A, Farmer A, Williamson R, McGuffin P, Young AH, Ferrier IN, Ball SG, Balmforth AJ, Barrett JH, Bishop DT, Iles MM, Maqbool A, Yuldasheva N, Hall AS, Braund PS, Burton PR, Dixon RJ, Mangino M, Suzanne S, Tobin MD, Thompson JR, Samani NJ, Bredin F, Tremelling M, Parkes M, Drummond H, Lees CW, Nimmo ER, Satsangi J, Fisher SA, Forbes A, Lewis CM, Onnie CM, Prescott NJ, Sanderson J, Mathew CG, Barbour J, Mohiuddin MK, Todhunter CE, Mansfeld JC, Ahmad T, Cummings FR, Jewell DP, Webster J, Brown MJ, Clayton DG, Lathrop GM, Connell J, Dominczak A, Samani NJ, Marcano CA, Burke B, Dobson R, Gungadoo J, Lee KL, Munroe PB, Newhouse SJ, Onipinla A, Wallace C, Xue M, Caulfeld M, Farrall M, Barton A, Bruce IN, Donovan H, Eyre S, Gilbert PD, Hider SL, Hinks AM, John SL, Potter C, Silman AJ, Symmmons DP, Thomson W, Worthington J, Clayton DG, Dunger DB, Nutland S, Stevens HE, Walker NM, Widmer B, Todd JA, Frayling TA, Freathy RM, Lango H, Perry JR, Shields BM, Weedon MN, Hattersley AT, Hitman GA, Walker M, Elliott KS, Groves CJ, Lindgren CM, Rayner NW, Timpson NJ, Zeggini E, McCarthy MI, Newport M, Sirugo G, Lyons E, Vanberg F, Hill AV, Bradbury LA, Farrar C, Pointon JJ, Wordsworth P, Brown MA, Franklyn JA, Heward JM, Simmonds MJ, Gough SC, Seal S, Stratton MR, Rahman N, Ban M, Goris A, Sawcer SJ, Compston A, Conway D, Jallow M, Newport M, Sirugo G, Rockett KA, Kwiatowski DP, Bumpstead SJ, Chaney A, Downes K, Ghori MJ, Gwilliam R, Hunt SE, Inouye M, Ke-niry A, King E, McGinnis R, Potter S, Ravindrarajah R, Whit-taker P, Widden C, Withers D, Deloukas P, Leung HT, Nut-land S, Stevens HE, Walker NM, Todd JA, Easton D, Clayton DG, Burton PR, Tobin MD, Barrett JC, Evans D, Morris AP, Cardon LR, Cardin NJ, Davison D, Ferreira T, Pereira-Gale J, Hallgrimsdottir IB, Howie BN, Marchini JL, Spencer CC, Su Z, Teo YY, Vukcevic D, Donnelly P, Bentley D, Brown MA, Gordon LR, Caulfield M, Clayton DG, Compston A, Craddock N, Deloukas P, Donnelly P, Farrall M, Gough SC, Hall AS, Hattersley AT, Hill AV, Kwiatkowski DP, Mathew C, McCarthy MI, Ouwehand WH, Parkes M, Pembrey M, Rahman N, Samani NJ, Stratton MR, Todd JA, Worthington J. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661-78
93. Pierik M, De Hertogh G, Vermeire S, Van Assche G, Van Eyken P, Joossens S, Claessens G, Vlietinck R, Rutgeerts P, Geboes K. Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease. Gut 2005; 54: 223-227
94. Mardini HE, Gregory KJ, Nasser M, Selby L, Arsenescu R, Winter TA, de Villiers WJ. Gastroduodenal Crohn's disease is associated with NOD2/CARD15 gene polymorphisms, particularly L1007P homozygosity. Dig Dis Sci 2005; 50: 2316-2322
95. Dambacher J, Staudinger T, Seiderer J, Sisic Z, Schnitzler F, Pfennig S, Hofbauer K, Konrad A, Tillack C, Otte JM, Diebold J, Göke B, Ochsenkühn T, Lohse P, Brand S. Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease. Infamm Bowel Dis 2007; 13: 71-82
96. Jyonouchi H, Geng L, Cushing-Ruby A, Monteiro IM. Aberrant responses to TLR agonists in pediatric IBD patients; the possible association with increased production of Th1/Th17 cytokines in response to candida, a luminal antigen. Pediatr Allergy Immunol 2010; 21: e747-e755
97. Thalmaier D, Dambacher J, Seiderer J, Konrad A, Schachinger V, Pfennig S, Otte JM, Crispin A, Göke B, Ochsenkühn T, Lohse P, Brand S. The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease. Aliment Pharmacol Ther 2006; 24: 1105-1115
98. Prescott NJ, Fisher SA, Franke A, Hampe J, Onnie CM, Soars D, Bagnall R, Mirza MM, Sanderson J, Forbes A, Mansfeld JC, Lewis CM, Schreiber S, Mathew CG. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology 2007; 132: 1665-1671
99. Koslowski MJ, Kübler I, Chamaillard M, Schaeffeler E, Rein-isch W, Wang G, Beisner J, Teml A, Peyrin-Biroulet L, Winter S, Herrlinger KR, Rutgeerts P, Vermeire S, Cooney R, Fell-ermann K, Jewell D, Bevins CL, Schwab M, Stange EF, We-hkamp J. Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease. PLoS One 2009; 4: e4496
100. Cummings JR, Ahmad T, Geremia A, Beckly J, Cooney R, Hancock L, Pathan S, Guo C, Cardon LR, Jewell DP. Contribution of the novel infammatory bowel disease gene IL23R to disease susceptibility and phenotype. Inflamm Bowel Dis 2007; 13: 1063-1068
101. Glas J, Seiderer J, Wetzke M, Konrad A, Török HP, Schmech-el S, Tonenchi L, Grassl C, Dambacher J, Pfennig S, Maier K, Griga T, Klein W, Epplen JT, Schiemann U, Folwaczny C, Lohse P, Göke B, Ochsenkühn T, Müller-Myhsok B, Folwac-zny M, Mussack T, Brand S. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS One 2007; 2: e819
102. Ouburg S, Mallant-Hent R, Crusius JB, van Bodegraven AA, Mulder CJ, Linskens R, Peña AS, Morré SA. The toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn's disease without a major role for the Saccharomyces cerevisiae mannan-LBP-CD14-TLR4 pathway. Gut 2005; 54: 439-440
103. Koon HW, Shih DQ, Chen J, Bakirtzi K, Hing TC, Law I, Ho S, Ichikawa R, Zhao D, Xu H, Gallo R, Dempsey P, Cheng G, Targan SR, Pothoulakis C. Cathelicidin signaling via the Tolllike receptor protects against colitis in mice. Gastroenterology 2011; 141: 1852-1863.e1-3
104. Waschke KA, Villani AC, Vermeire S, Dufresne L, Chen TC, Bitton A, Cohen A, Thomson AB, Wild GE. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes. Am J Gastroenterol 2005; 100: 1126-1133
105. Nam SY, Kim N, Kim JS, Lim SH, Jung HC, Song IS. Heat shock protein gene 70-2 polymorphism is differentially associated with the clinical phenotypes of ulcerative colitis and Crohn's disease. J Gastroenterol Hepatol 2007; 22: 1032-1038
106. Klausz G, Molnár T, Nagy F, Gyulai Z, Boda K, Lonovics J, Mándi Y. Polymorphism of the heat-shock protein gene Hsp70-2, but not polymorphisms of the IL-10 and CD14 genes, is associated with the outcome of Crohn's disease. Scand J Gastroenterol 2005; 40: 1197-1204
107. Alvarez-Lobos M, Arostegui JI, Sans M, Tassies D, Piu J, Re-verter JC, Pique JM, Yagüe J, Panés J. Combined type-1 plas-minogen activator inhibitor and NOD2/CARD15 genotyp-ing predicts complicated Crohn's disease behaviour. Aliment Pharmacol Ther 2007; 25: 429-440
108. Sans M, Tàssies D, Pellisé M, Espinosa G, Quintó L, Piqué JM, Reverter JC, Panés J. The 4G/4G genotype of the 4G/5G polymorphism of the type-1 plasminogen activator inhibitor (PAI-1) gene is a determinant of penetrating behaviour in patients with Crohn's disease. Aliment Pharmacol Ther 2003; 17: 1039-1047
109. Tomer G, Ceballos C, Concepcion E, Benkov KJ. NOD2/ CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease. Am J Gastroenterol 2003; 98: 2479-2484
110. Schicho R, Storr M. Alternative targets within the endocan-nabinoid system for future treatment of gastrointestinal diseases. Can J Gastroenterol 2011; 25: 377-383
111. Kugathasan S, Collins N, Maresso K, Hoffmann RG, Stephens M, Werlin SL, Rudolph C, Broeckel U. CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn' s disease. Clin Gastroenterol Hepatol 2004; 2: 1003-1009
112. Seiderer J, Elben I, Diegelmann J, Glas J, Stallhofer J, Tillack C, Pfennig S, Jürgens M, Schmechel S, Konrad A, Göke B, Och-senkühn T, Müller-Myhsok B, Lohse P, Brand S. Role of the novel Th17 cytokine IL-17F in infammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn' s disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Infamm Bowel Dis 2008; 14: 437-445
113. Barreiro M, Núñez C, Domínguez-Muñoz JE, Lorenzo A, Barreiro F, Potel J, Peña AS. Association of NOD2/CARD15 mutations with previous surgical procedures in Crohn's disease. Rev Esp Enferm Dig 2005; 97: 547-553
114. Odes S, Friger M, Vardi H, Claessens G, Bossuyt X, Riis L, Munkholm P, Wolters F, Yona H, Hoie O, Beltrami M, Tsia-nos E, Katsanos K, Mouzas I, Clofent J, Monteiro E, Messori A, Politi P, O'Morain C, Limonard C, Russel M, Vatn M, Moum B, Stockbrugger R, Vermeire S. Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Infammatory Bowel Disease. Infamm Bowel Dis 2007; 13: 874-881
115. Maconi G, Colombo E, Sampietro GM, Lamboglia F, D'Incà R, Daperno M, Cassinotti A, Sturniolo GC, Ardizzone S, Duca P, Porro GB, Annese V. CARD15 gene variants and risk of re-operation in Crohn's disease patients. Am J Gastroenterol 2009; 104: 2483-2491
116. Sarin R, Wu X, Abraham C. Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc Natl Acad Sci USA 2011; 108: 9560-9565
117. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Hueb-ner K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3; 8) breakpoint, is abnormal in digestive tract cancers. Cell 1996; 84: 587-597
118. Paradee W, Mullins C, He Z, Glover T, Wilke C, Opalka B, Schutte J, Smith DI. Precise localization of aphidicolin-in-duced breakpoints on the short arm of human chromosome 3. Genomics 1995; 27: 358-361
119. Barnes LD, Garrison PN, Siprashvili Z, Guranowski A, Robinson AK, Ingram SW, Croce CM, Ohta M, Huebner K. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase. Biochemistry 1996; 35: 11529-11535
120. Mendoza JL, Lana R, Martin MC, de la Concha EG, Urcelay E, Diaz-Rubio M, Abreu MT, Mitchell AA. FcRL3 gene promoter variant is associated with peripheral arthritis in Crohn' s disease. Infamm Bowel Dis 2009; 15: 1351-1357
121. Fan W, Maoqing W, Wangyang C, Fulan H, Dandan L, Jiaojiao R, Xinshu D, Binbin C, Yashuang Z. Relationship between the polymorphism of tumor necrosis factor-α-308 G& gt; A and susceptibility to infammatory bowel diseases and colorectal cancer: a meta-analysis. Eur J Hum Genet 2011; 19: 432-437
122. Laukens D, Peeters H, Marichal D, Vander Cruyssen B, Miel-ants H, Elewaut D, Demetter P, Cuvelier C, Van Den Berghe M, Rottiers P, Veys EM, Remaut E, Steidler L, De Keyser F, De Vos M. CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specifc phenotype previously related to Crohn's disease. Ann Rheum Dis 2005; 64: 930-935
123. Rodríguez-Pérez N, Aguinaga-Barrilero A, Gorroño-Echebarría MB, Pérez-Blas M, Martín-Villa JM. Analysis of Crohn' s disease-related CARD15 polymorphisms in Spanish patients with idiopathic uveitis. Dis Markers 2008; 24: 111-117
124. Peeters H, Vander Cruyssen B, Mielants H, de Vlam K, Ver-meire S, Louis E, Rutgeerts P, Belaiche J, De Vos M. Clinical and genetic factors associated with sacroiliitis in Crohn's disease. J Gastroenterol Hepatol 2008; 23: 132-137
125. Franke A, Fischer A, Nothnagel M, Becker C, Grabe N, Till A, Lu T, Müller-Quernheim J, Wittig M, Hermann A, Balsc-hun T, Hofmann S, Niemiec R, Schulz S, Hampe J, Nikolaus S, Nürnberg P, Krawczak M, Schürmann M, Rosenstiel P, Nebel A, Schreiber S. Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2. Gastroenterology 2008; 135: 1207-1215
126. Jakkula E, Leppä V, Sulonen AM, Varilo T, Kallio S, Kemp-pinen A, Purcell S, Koivisto K, Tienari P, Sumelahti ML, Elovaara I, Pirttilä T, Reunanen M, Aromaa A, Oturai AB, Søndergaard HB, Harbo HF, Mero IL, Gabriel SB, Mirel DB, Hauser SL, Kappos L, Polman C, De Jager PL, Hafler DA, Daly MJ, Palotie A, Saarela J, Peltonen L. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 2010; 86: 285-291
127. Schurr E, Gros P. A common genetic fngerprint in leprosy and Crohn's disease? N Engl J Med 2009; 361: 2666-2668
128. Weiss B, Lebowitz O, Fidder HH, Maza I, Levine A, Shaoul R, Reif S, Bujanover Y, Karban A. Response to medical treatment in patients with Crohn's disease: the role of NOD2/ CRAD15, disease phenotype, and age of diagnosis. Dig Dis Sci 2010; 55: 1674-1680
129. Angelberger S, Reinisch W, Dejaco C, Miehsler W, Waldhoer T, Wehkamp J, Lichtenberger C, Schaeffeler E, Vogelsang H, Schwab M, Teml A. NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fstulating Crohn's disease. Am J Gastroenterol 2008; 103: 1197-1202
130. Schwab M, Schäffeler E, Marx C, Fischer C, Lang T, Beh-rens C, Gregor M, Eichelbaum M, Zanger UM, Kaskas BA. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism. Pharmacogenetics 2002; 12: 429-436
131. Srimartpirom S, Tassaneeyakul W, Kukongviriyapan V, Tas-saneeyakul W. Thiopurine S-methyltransferase genetic polymorphism in the Thai population. Br J Clin Pharmacol 2004; 58: 66-70
132. McLeod HL, Pritchard SC, Githang'a J, Indalo A, Ameyaw MM, Powrie RH, Booth L, Collie-Duguid ES. Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specifcity in Caucasian and Kenyan individuals. Pharmacogenetics 1999; 9: 773-776
133. Dong XW, Zheng Q, Zhu MM, Tong JL, Ran ZH. Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of infammatory bowel disease. World J Gastro-enterol 2010; 16: 3187-3195
134. Lennard L. TPMT in the treatment of Crohn's disease with azathioprine. Gut 2002; 51: 143-146
135. Katsanos KH, Ferrante M, Henckaerts L, Joossens M, Schnit-zler F, Arijs I, Vermeulen N, Joossens S, Pierik M, Noman M, Van Assche G, Tsianos EV., Rutgeerts P, Vermeire S. The 2677T variant of the MDR1 gene and previous intolerance to azathioprine predict intolerance to methotrexate in infam-matory bowel disease. Gut 2006; 55 (SupplV): A20
136. Marzolini C, Paus E, Buclin T, Kim RB. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 2004; 75: 13-33
137. Todhunter CE, Sutherland-Craggs A, Bartram SA, Donaldson PT, Daly AK, Francis RM, Mansfeld JC, Thompson NP. Infuence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease. Gut 2005; 54: 1579-1584
138. Gelbmann CM, Rogler G, Gierend M, Gross V, Schölmerich J, Andus T. Association of HLA-DR genotypes and IL-1ra gene polymorphism with treatment failure of budesonide and disease patterns in Crohn's disease. Eur J Gastroenterol Hepatol 2001; 13: 1431-1437
139. Lakatos PL, Szamosi T, Szilvasi A, Molnar E, Lakatos L, Ko-vacs A, Molnar T, Altorjay I, Papp M, Tulassay Z, Miheller P, Papp J, Tordai A, Andrikovics H. ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients. Dig Liver Dis 2008; 40: 867-873
140. Griga T, Wilkens C, Wirkus N, Epplen J, Schmiegel W, Klein W. A polymorphism in the macrophage migration inhibitory factor gene is involved in the genetic predisposition of Crohn's disease and associated with cumulative steroid doses. Hepatogastroenterology 2007; 54: 784-786
141. Louis E, El Ghoul Z, Vermeire S, Dall'Ozzo S, Rutgeerts P, Paintaud G, Belaiche J, De Vos M, Van Gossum A, Colombel JF, Watier H. Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infix-imab in Crohn's disease. Aliment Pharmacol Ther 2004; 19: 511-519
142. Willot S, Vermeire S, Ohresser M, Rutgeerts P, Paintaud G, Belaiche J, De Vos M, Van Gossum A, Franchimont D, Co-lombel JF, Watier H, Louis E. No association between C-reac-tive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease. Pharmacogenet Genomics 2006; 16: 37-42
143. Louis E, Vermeire S, Rutgeerts P, De Vos M, Van Gossum A, Pescatore P, Fiasse R, Pelckmans P, Reynaert H, D'Haens G, Malaise M, Belaiche J. A positive response to infiximab in Crohn disease: association with a higher systemic infamma-tion before treatment but not with -308 TNF gene polymorphism. Scand J Gastroenterol 2002; 37: 818-824
144. Pierik M, Vermeire S, Steen KV, Joossens S, Claessens G, Vlietinck R, Rutgeerts P. Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in infammatory bowel disease and their association with response to infliximab. Aliment Pharmacol Ther 2004; 20: 303-310
145. Strober W, Watanabe T. NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease. Mucosal Immunol 2011; 4: 484-495
146. Emily M, Mailund T, Hein J, Schauser L, Schierup MH. Using biological networks to search for interacting loci in genomewide association studies. Eur J Hum Genet 2009; 17: 1231-1240
147. Vermeire S, Rutgeerts P, Van Steen K, Joossens S, Claessens G, Pierik M, Peeters M, Vlietinck R. Genome wide scan in a Flemish infammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis. Gut 2004; 53: 980-986
148. Lettre G, Rioux JD. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 2008; 17: R116-R121
149. Satsangi J, Jewell D, Parkes M, Bell J. Genetics of infamma-tory bowel disease. A personal view on progress and prospects. Dig Dis 1998; 16: 370-374
150. Raelson JV, Little RD, Ruether A, Fournier H, Paquin B, Van Eerdewegh P, Bradley WE, Croteau P, Nguyen-Huu Q, Segal J, Debrus S, Allard R, Rosenstiel P, Franke A, Jacobs G, Niko-laus S, Vidal JM, Szego P, Laplante N, Clark HF, Paulussen RJ, Hooper JW, Keith TP, Belouchi A, Schreiber S. Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci. Proc Natl Acad Sci USA 2007; 104: 14747-14752
151. Mathew CG. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat Rev Genet 2008; 9: 9-14
152. Noble CL, Abbas AR, Lees CW, Cornelius J, Toy K, Modru-san Z, Clark HF, Arnott ID, Penman ID, Satsangi J, Diehl L. Characterization of intestinal gene expression profles in Crohn's disease by genome-wide microarray analysis. In-famm Bowel Dis 2010; 16: 1717-1728
153. Fisher SA, Lewis CM. Power of genetic association studies in the presence of linkage disequilibrium and allelic heterogeneity. Hum Hered 2008; 66: 210-222
154. Onomou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004; 99: 2393-2404
155. Okazaki T, Wang MH, Rawsthorne P, Sargent M, Datta LW, Shugart YY, Bernstein CN, Brant SR. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions. Infamm Bowel Dis 2008; 14:1528-1541
156. Zhang W, Chen Y, Sun F, Jiang R. DomainRBF: a Bayesian regression approach to the prioritization of candidate domains for complex diseases. BMC Syst Biol 2011; 5: 55